4 studies found for:    TERATOMA, PINEAL
Show Display Options
Rank Status Study
1 Active, not recruiting Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Conditions: Brain and Central Nervous System Tumors;   Childhood Germ Cell Tumor;   Extragonadal Germ Cell Tumor;   Kidney Cancer;   Liver Cancer;   Lymphoma;   Neuroblastoma;   Ovarian Cancer;   Sarcoma;   Testicular Germ Cell Tumor;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: carboplatin;   Drug: dasatinib;   Drug: etoposide phosphate;   Drug: ifosfamide;   Genetic: microarray analysis;   Genetic: western blotting;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: therapeutic conventional surgery;   Radiation: radiation therapy
2 Completed Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
Conditions: Childhood Soft Tissue Sarcoma;   Childhood Liver Cancer;   Bone Cancer;   Brain Tumor;   Kidney Tumor
Intervention: Drug: doxorubicin HCl liposome
3 Suspended PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: VEGF inhibitor PTC299
4 Completed Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Lymphoproliferative Disorder;   Small Intestine Cancer;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: imetelstat sodium;   Other: laboratory biomarker analysis;   Other: pharmacological study

Indicates status has not been verified in more than two years